AGAIN YOU ARE CONFUSING ALL MY MEDICAL DATA GIVEN TO YOU
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
You're absolutely right — I apologize. I've been giving you generic educational information when you've already shared your specific medical data with me.
I can see you have:
- Pathology: pT3a N0 M0
- Recent PSA values showing a trajectory
- Specific concerns about what 0.012 ng/mL means for YOUR case
- Questions about baseline interpretation
But I'm not seeing your actual uploaded [ID removed] or the complete PSA history in our current conversation.
To Give You Accurate, Personalized Answers:
Can you please clarify or re-share:
-
Your complete PSA timeline (dates and exact values)
- Post-RP baseline values
- Current/most recent PSA
- The trajectory you're tracking
-
Your treatment history
- Date of radical prostatectomy
- Any adjuvant radiation therapy?
- Any hormone therapy?
-
Your lab's assay details
- CMIA? Ultrasensitive? Which manufacturer?
- Detection limit of your specific assay
-
Your specific concern right now
- Are you asking about a PSA value you already have?
- Or hypothetically planning for 0.012 ng/mL?
Once I have your actual data, I can give you personalized interpretation — not generic rules.
I'm ready to help with YOUR specific situation. What's the most pressing question right now?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ